- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Hong Kong Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)
Results
109
Most Searched for companies on Simply Wall St (as in this app) ... to be used for "Trending" stocks
109 companies
3SBio
Market Cap: HK$49.1b
An investment holding company, develops, produces markets, and sells biopharmaceutical products in Mainland China and internationally.
1530
HK$20.80
7D
-10.7%
1Y
242.7%
China Traditional Chinese Medicine Holdings
Market Cap: HK$11.1b
China Traditional Chinese Medicine Holdings Co.
570
HK$2.20
7D
-5.6%
1Y
-48.0%
Consun Pharmaceutical Group
Market Cap: HK$9.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$11.14
7D
-0.2%
1Y
104.4%
RemeGen
Market Cap: HK$34.8b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.
9995
HK$52.00
7D
-2.9%
1Y
98.5%
Lepu Biopharma
Market Cap: HK$10.0b
A biopharmaceutical company, focuses on the discovery, development, and commercialization of first-in class and best-in-class drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally.
2157
HK$5.82
7D
-1.7%
1Y
43.7%
Modern Chinese Medicine Group
Market Cap: HK$210.0m
An investment holding company, engages in the production and sale of proprietary Chinese medicines for elderlies and middle aged in the People's Republic of China.
1643
HK$0.35
7D
-1.4%
1Y
-13.6%
Essex Bio-Technology
Market Cap: HK$2.6b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.55
7D
-10.6%
1Y
83.5%
Luye Pharma Group
Market Cap: HK$12.5b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$3.32
7D
-15.3%
1Y
16.9%
Regent Pacific Group
Market Cap: HK$228.4m
An investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
575
HK$1.00
7D
-7.4%
1Y
63.9%
TransThera Sciences (Nanjing)
Market Cap: HK$5.2b
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.
2617
HK$13.15
7D
n/a
1Y
n/a
Kintor Pharmaceutical
Market Cap: HK$642.6m
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$1.48
7D
-11.9%
1Y
34.5%
Brii Biosciences
Market Cap: HK$1.2b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$1.71
7D
-16.2%
1Y
56.9%
Duality Biotherapeutics
Market Cap: HK$21.2b
A clinical-stage biotech company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.
9606
HK$240.80
7D
-11.9%
1Y
n/a
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$7.0b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$8.37
7D
-3.5%
1Y
-8.1%
Frontage Holdings
Market Cap: HK$2.3b
A contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.
1521
HK$1.16
7D
-5.7%
1Y
27.5%
Shanghai Henlius Biotech
Market Cap: HK$26.1b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$48.00
7D
0.4%
1Y
n/a
VISEN Pharmaceuticals
Market Cap: HK$5.5b
An investment holding company, engages in the development and commercialization of endocrine therapies in the People’s Republic of China, Hong Kong, and Taiwan.
2561
HK$48.70
7D
-3.1%
1Y
n/a
PegBio
Market Cap: HK$3.5b
A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.
2565
HK$9.06
7D
0.4%
1Y
n/a
JW (Cayman) Therapeutics
Market Cap: HK$1.0b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$2.58
7D
14.7%
1Y
24.6%
Sirnaomics
Market Cap: HK$447.6m
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$4.29
7D
-0.5%
1Y
-20.3%
Jiangsu Recbio Technology
Market Cap: HK$4.0b
A vaccine company, engages in the research, development, and commercialization of subunit vaccines in the People’s Republic of China.
2179
HK$8.46
7D
1.9%
1Y
-7.7%
China NT Pharma Group
Market Cap: HK$279.8m
An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China and Hong Kong.
1011
HK$0.41
7D
-5.7%
1Y
48.2%
Austar Lifesciences
Market Cap: HK$358.8m
An investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally.
6118
HK$0.70
7D
-2.8%
1Y
1.4%
SSY Group
Market Cap: HK$8.0b
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.
2005
HK$2.71
7D
-6.9%
1Y
-39.8%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$5.1b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$12.60
7D
-4.8%
1Y
-13.0%
Ascletis Pharma
Market Cap: HK$9.3b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$9.62
7D
1.9%
1Y
968.9%
Jacobio Pharmaceuticals Group
Market Cap: HK$3.8b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$4.88
7D
-5.6%
1Y
199.4%
Wai Yuen Tong Medicine Holdings
Market Cap: HK$382.5m
An investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
897
HK$0.34
7D
-2.9%
1Y
58.1%
SinoMab BioScience
Market Cap: HK$2.5b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.
3681
HK$2.10
7D
-12.1%
1Y
26.5%
Everest Medicines
Market Cap: HK$15.9b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$49.05
7D
-2.8%
1Y
147.7%
Abbisko Cayman
Market Cap: HK$7.0b
An investment holding company, engages in the research and development of pharmaceutical products in the People’s Republic of China.
2256
HK$10.38
7D
1.4%
1Y
232.7%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$9.8b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.07
7D
-7.8%
1Y
94.5%
Immunotech Biopharm
Market Cap: HK$1.6b
A cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China.
6978
HK$3.07
7D
0.7%
1Y
-1.9%
Kontafarma China Holdings
Market Cap: HK$156.5m
An investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally.
1312
HK$0.028
7D
7.7%
1Y
-22.2%
CK Life Sciences Int'l. (Holdings)
Market Cap: HK$8.2b
An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.
775
HK$0.85
7D
-5.6%
1Y
153.7%
3D Medicines
Market Cap: HK$1.0b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$4.12
7D
-3.1%
1Y
-31.3%